Multivariate analysis results
| . | N . | HR (95% CI) . | P value . |
|---|---|---|---|
| OS | |||
| Age (y) at HCT | |||
| <60 | 92 | Reference | |
| ≥60 | 72 | 2.16 (1.35-3.46) | .001 |
| Disease status | |||
| CR1 | 121 | Reference | |
| PIF/CR2/relapse | 43 | 1.87 (1.14-3.06) | .01 |
| DFS | |||
| Disease status | |||
| CR1 | 121 | Reference | |
| PIF/CR2/relapse | 42 | 1.75 (1.11-2.76) | .02 |
| Conditioning intensity/TBI usage | .003 | ||
| MAC/TBI | 43 | Reference | |
| MAC/no TBI | 41 | 2.89 (1.41-5.94) | .004 |
| RIC/NMA | 79 | 3.09 (1.59-5.98) | .001 |
| RIC/NMA vs MAC/no TBI | 1.07 (0.66-1.73) | .79 | |
| Relapse | |||
| Conditioning intensity/TBI usage | .03 | ||
| MAC/TBI | 43 | Reference | |
| MAC/no TBI | 41 | 3.28 (1.27-8.5) | .01 |
| RIC/NMA | 79 | 3.13 (1.29-7.61) | .01 |
| RIC/NMA vs MAC/no TBI | 0.95 (0.51-1.80) | .88 | |
| NRM | |||
| Age (y) at HCT | |||
| <60 | 92 | Reference | |
| ≥60 | 71 | 2.19 (1.13-4.22) | .02 |
| . | N . | HR (95% CI) . | P value . |
|---|---|---|---|
| OS | |||
| Age (y) at HCT | |||
| <60 | 92 | Reference | |
| ≥60 | 72 | 2.16 (1.35-3.46) | .001 |
| Disease status | |||
| CR1 | 121 | Reference | |
| PIF/CR2/relapse | 43 | 1.87 (1.14-3.06) | .01 |
| DFS | |||
| Disease status | |||
| CR1 | 121 | Reference | |
| PIF/CR2/relapse | 42 | 1.75 (1.11-2.76) | .02 |
| Conditioning intensity/TBI usage | .003 | ||
| MAC/TBI | 43 | Reference | |
| MAC/no TBI | 41 | 2.89 (1.41-5.94) | .004 |
| RIC/NMA | 79 | 3.09 (1.59-5.98) | .001 |
| RIC/NMA vs MAC/no TBI | 1.07 (0.66-1.73) | .79 | |
| Relapse | |||
| Conditioning intensity/TBI usage | .03 | ||
| MAC/TBI | 43 | Reference | |
| MAC/no TBI | 41 | 3.28 (1.27-8.5) | .01 |
| RIC/NMA | 79 | 3.13 (1.29-7.61) | .01 |
| RIC/NMA vs MAC/no TBI | 0.95 (0.51-1.80) | .88 | |
| NRM | |||
| Age (y) at HCT | |||
| <60 | 92 | Reference | |
| ≥60 | 71 | 2.19 (1.13-4.22) | .02 |
PIF, primary induction failure.